Patient Care

Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)

If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney...

CliniComp Introduces Intrinsic AI™: Revolutionizing Healthcare IT with Native, Clinician-Designed Artificial Intelligence

Seamlessly integrated into CliniComp's advanced EHR Solution Suite, Intrinsic AI™ streamlines workflows, enhances efficiency, and reduces cognitive burden without requiring additional...

FINN Partners and Humble Ventures Expanded ‘Future of Education and Health’ Returns to Austin on Thursday, March 6 – Friday, March 7 at Atelier 1205

Two immersive future-focused days of programming in education and health, bringing together leading innovators, VCs, policymakers, researchers and entrepreneurs for...

HIMSS25: FDB to Spotlight Customer Success Stories and Innovative Drug Knowledge Solutions

From Integrating Real-Time Pharmacogenomics to Boosting Medication Adherence, Healthcare Organizations Are Realizing the Benefits of Advanced Medication Decision Support SOUTH...

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis

Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales...

error: Content is protected !!